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Department of Epidemiology and Public Health, Yale University School of Medicine, New Haven, Connecticut; Department of
Virology, Armed Forces Research Institute of Medical Sciences, Bangkok, Thailand; Department of Pediatrics,
Bangkok Children’s Hospital, Bangkok, Thailand; Department of Medicine, University of Massachusetts Medical Center,
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Abstract. Dengue is a mosquito-borne viral infection that in recent years has become a major international public
health concern. Dengue hemorrhagic fever (DHF), first recognized in Southeast Asia in the 1950s, is today a leading
cause of childhood death in many countries. The pathogenesis of this illness is poorly understood, mainly because
there are no laboratory or animal models of disease. We have studied the genetic relationships of dengue viruses of
serotype 2, one of four antigenically distinct dengue virus groups, to determine if viruses obtained from cases of less
severe dengue fever (DF) have distinct evolutionary origins from those obtained from DHF cases. A very large
number (73) of virus samples from patients with DF or DHF in two locations in Thailand (Bangkok and Kamphaeng
Phet) were compared by sequence analysis of 240 nucleotides from the envelope/nonstructural protein 1 (E/NS1)
gene junction of the viral genome. Phylogenetic trees generated with these data have been shown to reflect long-term
evolutionary relationships among strains. The results suggest that 1) many different virus variants may circulate
simultaneously in Thailand, thus reflecting the quasispecies nature of these RNA viruses, in spite of population
immunity; 2) viruses belonging to two previously distinct genotypic groups have been isolated from both DF and
DHF cases, supporting the view that they arose from a common progenitor and share the potential to cause severe
disease; and 3) viruses associated with the potential to cause DHF segregate into what is now one, large genotypic
group and they have evolved independently in Southeast Asia for some time.
Dengue virus, a mosquito-borne Flavivirus, is responsible
for a growing number of human infections worldwide, main-
ly in tropical, urban, and periurban areas, as a function of
the distribution of its vector. The majority of cases present
with classic dengue fever (DF), a systemic, self-limited ill-
ness, but some individuals develop a more severe form of
the disease, dengue hemorrhagic fever (DHF), with plasma
leakage and thrombocytopenia: mortality rates are approxi-
mately 5%. There are four closely related, but antigenically
distinct dengue serotypes (types 1-4); infection by one se-
rotype virus does not protect against infection by a second
serotype virus. Based on epidemiologic and laboratory ob-
servations, it has been shown that cross-reactive immune
responses, including infection-enhancing antibodies, contrib-
ute to the higher frequency of DHF in children with sequen-
tial infections or infants born to dengue-immune mothers1, 2
The lack of in vitro and in vivo models of severe dengue
disease have hampered studies of the pathogenesis and def-
inition of factors involved in producing DHF. Thus, it is
presently unclear whether viral virulence factors contribute
to severe dengue; the association of the introduction of spe-
cific genetic types of dengue serotype 2 and the appearance
of DHF in the Americas has suggested that this may be the
case. Two genetic variants (or genotypes) of serotype 2,
which seem to have originated in Southeast Asia, have been
isolated from DHF patients in Mexico and South America3;
it is therefore important to have a better understanding of
the molecular evolution of dengue viruses in Southeast Asia,
a probable source of virulent variants to other continents.
Thailand has had a long history of dengue virus trans-
mission, with all four dengue virus serotypes causing peri-
odic outbreaks, with high numbers of DF and DHF cases
reported annually since the 1950s.1, 4 Dengue serotype 2 vi-
ruses have been associated most frequently with DHF in this
country (Nisalak A, unpublished data); this group of viruses
has therefore been the subject of previous genetic variation
studies.5, 6 We have studied the genetic relationships of 73
dengue viruses of serotype 2 from two areas of Thailand,
Bangkok and Kainphaeng Phet, isolated over a 32-year pe-
riod, using limited sequencing and phylogenetic analyses, to
determine if there are specific associations between virus
genetic type and severity of clinical presentation. This evo-
lutionary study has also helped us understand the transmis-
sion patterns of virus variants through a population that is
being infected regularly in a hyperendemic disease cycle.
MATERIALS AND METHODS
Viruses. Dengue viruses used in this study were selected
from frozen stocks or from plasma collected during ongoing
prospective clinical studies (a total of 73 from Thailand);7, 8
virus aliquots were used to infect C6/36 mosquito cells and
were identified as dengue serotype 2 by indirect fluorescent
antibody tests with type-specific monoclonal antibodies.9 Vi-
rus isolation and passage histories are given in Table 1; vi-
ruses or nucleic acids described here were isolated or am-
plified from human plasma, except strain PM33974, which
was isolated from a mosquito pool.
Extraction of RNA and reverse transcriptase–poly-
merase chain reaction (RT-PCR). Nucleotide sequences
for six of the 77 dengue type 2 viruses described here were
obtained previously by primer-extension sequencing from vi-
ral-extracted RNA;10 the remainder were amplified by RT-
PCR. Sequences obtained by these two methods have shown
no differences over the 240-nucleotide-long envelope/non-
structural protein 1 (E/NS1) region used for phylogenies.3
For 71 of the viruses shown here, a 100–200-ml aliquot
of cell culture supernatant or human plasma was treated with
1.0 ml of Trizol (GIBCO-BRL, Gaithersburg, MD); RNA
extractions were done according to the manufacturer’s pro-
tocol. The RNA was resuspended in water and one-fifth of
this sample was added to Superscript II RT buffer (50 mM
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Tris-HCl, 75 mM KCl, 3 mM MgCl2, pH 8.3) (GIBCO-
BRL), 10 mM DTT, and 50 pM of an antisense primer
(D2/2578: 59-TTACTGAGCGGATTCCACAGATGCC-39)
that hybridizes to all known dengue serotype 2 viruses.10 The
solution was heated to 908C for 90 sec, and cooled on ice.
Each of the four deoxynucleotides were added (1 mM) along
with 40 U of RNasin (Promega, Madison, WI) and 200 U
of reverse transcriptase enzyme (Superscript II; GIBCO-
BRL). The mixture was incubated for 1 hr at 428C and
cooled on ice. To this mixture both PCR primers (D2/2578
and D2/2170V: 59-ATGGCCATTTTAGGTGACACAGCC-
TGGGA-39, sense) were added (150 pM), PCR buffer at pH
10.0 (60 mM Tris-HCl, 15 mM (NH4)2SO4, 1.5 mM MgCl2),
deoxynucleotides at 0.2 mM, and the volume brought up to
50 ml with water. Amplitaq enzyme (Perkin Elmer, Foster
City, CA) was added last (5 U) and the solution overlaid
with mineral oil. The samples, including a positive PCR con-
trol (Perkin Elmer), a negative control (water), and a dengue
type 2 RNA control, were placed in a thermal cycler for 30
cycles at 948C for 60 sec, 558C for 2 min, and 728C for 3
min. The samples were kept at 48C after amplification. The
entire sample was electrophoresed in a 2% NuSieve GTG
agarose gel (FMC Bioproducts, Rockland, ME) and stained
with 1 mg/ml of ethidium bromide for visualization of bands.
This procedure produced a 408-basepair (bp) product for se-
quencing; the 240-nucleotide fragment for genetic compari-
son is comprised within this product. Specific amplification
of RNA from virus strains belonging to five previously de-
scribed genotypes10 were obtained in this manner.
Polymerase chain reaction fragment sequencing. Bands
of the correct size were cut from agarose gels and equili-
brated in b-Agarase buffer (10 mM Tris-HCl, 1 mM EDTA,
pH 6.5) (New England Biolabs, Beverly, MA). Agarose was
digested with 6 U of b-Agarase enzyme (New England Biol-
abs) and the DNA fragments were precipitated and washed
in ethanol, according to the manufacturer’s instructions. The
DNA was resuspended in water and one-fourth of this sam-
ple used in dideoxynucleotide sequencing reactions. Se-
quencing was done manually using the Sequenase 2.0 Kit
(USB, Amersham, Cleveland, OH), according to the manu-
facturer’s instructions, including pyrophosphatase and a-35S-
dATP. Two primer-extension reactions using the D2/2578
primer and D2/2452 (59-CCACATTTCAGTTCTTT-39) pro-
vided clear results and overlap at the 240-nucleotide site
used for comparisons (map sites 2311-2550).11
Sequence analysis and phylogenies. Nucleotide sequenc-
es for six of the strains shown here were reported previ-
ously10 and the remainder were submitted to GenBank; ac-
cession numbers are given in Table 1. Sequences for the
homologous region of serotype 1 virus (strain D81-135,
Thailand, 1981), serotype 3 virus (strain H87, Philippines,
1956), and serotype 4 virus (strain 814669, Dominica, 1981)
were obtained from GenBank (accession numbers M32925,
M93130, and M14931, respectively). Alignments were done
using encoded amino acids; none of the viruses compared
here had additions or deletions in this region of the genome.
Phylogenetic analyses were done using the phylogenetic
analysis using parsimony (PAUP) program, with uniform
character weights, tree bisection-reconnection branch-swap-
ping, and a heuristic search for most parsimonious trees.12
Sequences from representatives of the other three serotypes
(1, 3, and 4) were used as an outgroup to root the trees. The
reliability of the inferred trees was estimated using the boot-
strap method, with 100 replications.13
RESULTS
The maximum parsimony analysis of nucleotide sequences
resulted in an evolutionary tree, with branching patterns pro-
portional to genetic relatedness among strains. The most reli-
able tree for all of the samples described in Table 1 is shown
in Figure 1. All dengue serotype 2 viruses segregated into one
large group consisting of samples from different geographic
locations, with those from Guinea (1981), Sri Lanka (1985),
and Puerto Rico (1969) each representing a distinct genotypic
group, as inferred from the bootstrap values (range 5 100–52).
Samples from Thailand fell into two groups that had previously
been classified as distinct;10 bootstrap values for these two
groups were less than 50 and their separation is no longer sup-
ported. The inclusion of many more variants of these genotypic
groups has blurred their separation (see Discussion). Therefore,
the total number of dengue genotypic groups determined by
this method have been reduced from five to four. Other than
this observation, there were no major differences in the branch-
ing patterns of the evolutionary tree generated by maximum
parsimony (PAUP; shown here) and that generated previously,
using another algorithm, the NUCLDIFF program, which is
based on pairwise distances.10
The results obtained here do not differ substantially from
those obtained by others when comparing full E gene or NS1
gene sequences of dengue type 2 viruses from Thailand.14–16
The major branching patterns were the same for those vi-
ruses that were included in both studies; however, bootstrap
values of statistical significance of branching patterns were
not available for previous studies. Other studies of genetic
variation of dengue type 2 viruses in Thailand using oligo-
nucleotide fingerprinting techniques5, 6 also agree with results
reported here. Because of the large number of strains ana-
lyzed in one report,6 it was easier to make comparisons;
there were a total of nine strains in common with our study.
The genetic relationships represented in the phylogenetic
tree shown here were most similar to those reflected in the
dendrogram generated with fingerprinting data. Because fin-
gerprinting surveys approximately 10% of the viral ge-
nome,17 we are confident that the comparison of sequences
from the E/NS1 junction yields reliable estimates of genetic
relationships among these viruses.
As can be seen in Figure 1, many variants of dengue type
2 viruses have been transmitted in Thailand over a 32-year
period. There was no segregation of viruses according to
location in Thailand; the two areas from which specimens
were collected, Bangkok and Kamphaeng Phet, are 360 km
apart. Samples obtained during the same year (e.g., 1980 or
1994) fall into different genetic clusters although they are
from the same city (Bangkok). This variation, although sig-
nificant in some cases (e.g., 11 of 240 nucleotides or 4.6%
divergence between PUO-218 and PUO-280, and 22 of 240
or 9.2% between PUO-218 and D80-141, all from 1980; or
7 of 240, 2.9% divergence between CO562 and CO576,
from 1994) confirms the quasispecies nature of RNA viruses
during natural transmission.18 A previous study had shown
that the genetic relationships demonstrated by the compari-
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TABLE 1
Dengue type 2 viruses compared by sequence analysis
Strain Passage history* Location† Year
Clinical
status‡
Accession
no.§
NGC
16681
PR159
D79-014
D79-069
PUO-218
PUO-280
D80-038
D80-100
D80-141
Monk.1, mosq.1, C6/361
MK2 1, C6/36 5
PGMK 6
MK2 2, C6/36 1
MK2 2, C6/36 1
MK2 2, C6/36 1
MK2 2, C6/36 1
MK2 2, C6/36 1
MK2 2, C6/36 1
MK2 2, C6/36 1
New Guinea
Bangkok, Thailand
Puerto Rico
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
1944
1964
1969
1979
1979
1980
1980
1980
1980
1980
DF
DHF
DF
DF
DHF
DF
DF
DHF
DHF
DHF
M32941
M32947
M32953
U87320
U87319
U87331
U87377
U87366
U87339
U87321
D80-159
PM33974
D81-004
D81-081
D82-033
D82-137
D83-516
D84-015
D84-087
D84-237
MK2 2, C6/36 1
Mosq.1, C6/36 1
C6/36 1
C6/36 1
C6/36 1
C6/36 1
Ts 1, C6/36 2
Ts 1, C6/36 2
Ts 1, C6/36 2
Ts 1, C6/36 2
Bangkok, Thailand
Republic of Guinea
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
1980
1981
1981
1981
1982
1982
1983
1984
1984
1984
DHF
–
DF
DHF
DHF
DF
DF
DF
DHF
DHF
U87322
M32962
U87368
U87340
U87365
U87341
M32967
U87323
U87369
U87371
975
D86-004
D86-337
D87-1036
D87-1372
D88-007
D88-065
D89-633
D89-1092
D90-206
C6/36 3
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Sri Lanka
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
1985
1986
1986
1987
1987
1988
1988
1989
1989
1990
DF
DHF
DF
DHF
DF
DF
DHF
DF
DHF
DF
M32966
U87324
U87325
U87372
U87326
U87373
U87374
U87367
U87327
U87376
D90-276
D91-104
D91-157
D91-409
D91-419
KD91-068
KD91-113
KPH-13773
KPH-15008
KD92-021
KD92-097
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
1990
1991
1991
1991
1991
1991
1991
1991
1991
1992
1992
DHF
DF
DHF
DHF
DHF
DHF
DHF
DF
DF
DHF
DHF
U87330
U87328
U87329
U87332
U87335
U87342
U87343
U87334
U87333
U87358
U87338
KD92-207
KPH-63652
D92-030
D92-110
D92-129
D92-287
KD93-390
KD93-439
K0005/94
K0006/94
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
Ts 1, C6/36 1
None
None
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
1992
1992
1992
1992
1992
1992
1993
1993
1994
1994
DHF
DF
DHF
DHF
DF
DF
DHF
DHF
DHF
DF
U87351
U87363
U87336
U87364
U87359
U87337
U87375
U87344
U87346
U87347
K0011/94
K0027/94
K0060/94
K0074/94
K0097/94
K0142/94
K0146/94
C0257/94
C0385/94
C0441/94
None
None
None
None
None
None
None
None
None
None
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
1994
1994
1994
1994
1994
1994
1994
1994
1994
1994
DHF
DHF
DF
DF
DHF
DHF
DF
DF
DHF
DHF
U87352
U87360
U87361
U87349
U87348
U87350
U87353
U87370
U87345
U87387
C0501/94
C0507/94
C0562/94
C0576/94
C0590/94
K0047/95
K0049/95
K0079/95
None
None
None
None
None
None
None
None
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
Kamphaeng Phet, Thailand
1994
1994
1994
1994
1994
1995
1995
1995
DF
DF
DHF
DHF
DHF
DHF
DHF
DHF
U87354
U87362
U87355
U87356
U87357
U87383
U87384
U87382
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TABLE 1
Continued
Strain Passage history* Location† Year
Clinical
status‡
Accession
no.§
C0059/95
C0084/95
C0195/95
C0235/95
C0371/95
C0390/95
C0452/95
C0477/95
None
None
None
None
None
None
None
None
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
Bangkok, Thailand
1995
1995
1995
1995
1995
1995
1995
1995
DHF
DHF
DF
DHF
DF
DHF
DHF
DHF
U87378
U87379
U87385
U87380
U87386
U87381
U87388
U87389
* Monk. 5 rhesus monkey; Mosq. 5 whole mosquito, species unknown; C6/36 5 Aedes albopictus cell line; MK2 5 LLC-MK2 monkey kidney cell line; PGMK 5 primary green monkey
kidney cell line; Ts 5 Toxorynchites splendens mosquito; None 5 acute plasma of patient.
† City and/or country.
‡ DF 5 dengue fever; DHF 5 dengue hemorrhagic fever; – 5 Aedes africanus isolate.
§ GenBank accession number.
son of this 240-nucleotide region are maintained independent
of passage level of virus strains (e.g., PR159 and its atten-
uated derivative PR159S1, which had undergone 23 cell cul-
ture passes, were identical).10 The results obtained here con-
firm this because there was no segregation of strains based
on whether their sequences were determined from passaged
virus or by RT-PCR of template from plasma. Because nu-
cleotides from this region of the genome encode amino acids
that are apparently not under immune selection (they are
internal on the virion structure),10 the phylogenies reflect
only genetic relationships among strains and are probably
not reflective of pathogenesis differences (i.e., they do not
encode antigenic sites that may be involved in virulence or
immune enhancement of infection). Therefore, these rela-
tionships should be interpreted carefully, as a reflection of
virus evolution only.
The wide distribution of samples from DF and DHF pa-
tients seen in Figure 1 confirms that viruses from this area
of the world (Southeast Asia) have the potential to cause
severe disease and they share a common progenitor. In fact,
results presented here and elsewhere suggest that viruses be-
longing to this Southeast Asian genotypic group have been
responsible for the emergence of DHF in the Americas,3 be-
ginning with the 1981 epidemic in Cuba.10 All dengue type
2 virus samples from DHF patients studied to date in our
laboratories have fallen into this genotypic group, regardless
of where or when they were obtained.
DISCUSSION
The wide range of samples we included in this study al-
lowed us to observe the swarms of virus variants that orig-
inate from a common progenitor (i.e., the branches or clades
of variants within a genotypic group) and the elimination of
the division between the two genotypes from Southeast Asia
(i.e., the two genotypic groups containing viruses from Thai-
land). The fact that these viruses did not segregate into
branches with a linear progression of mutations over time
(i.e., some variants reverted to previous consensus sequenc-
es) suggests that there is a large amount of plasticity in the
E/NS1 region of the genome but we can still observe long-
term evolutionary trends. Thus, as we analyze more samples
of dengue type 2 viruses from around the world, we will
probably have sampled enough natural variants to reflect the
true plasticity of the dengue genome and our arbitrary group-
ing of variants into four genotypes will become blurred, al-
though probably maintaining some segregation due to dif-
fering biologic properties (i.e., phenotype). We have no ev-
idence to support that one variant is more stable, as a pop-
ulation, over another, but we are probably seeing only those
mutants that are more successful at surviving because they
have been isolated from acutely infected hosts and are being
transmitted. These results point to the need for evolutionary
studies of dengue populations in single individuals (humans
and mosquitoes) to gain a better understanding of the rates
of mutation or plasticity of the viral genome and the influ-
ence of host factors on that population of variants.
In terms of one of the most important questions concern-
ing dengue pathogenesis, there was no segregation of DF-
versus DHF-associated viruses on the evolutionary tree.
There was no clear-cut evolutionary divergence or branching
of DF versus DHF isolates; it is apparent that these viruses
in Thailand share the same ancestor or progenitors. Thus,
this virus lineage is capable of continuously generating var-
iants with the potential to cause severe disease. This obser-
vation, based on comparing an area of the genome that is
not involved in immune recognition/stimulation, can be ex-
pected since we were using these sequences as markers for
long-term evolutionary trends. Current work is aimed at
comparing the full sequence of the dengue type 2 virus ge-
nome from DF and DHF patients with carefully obtained
clinical and immunologic data. This might lead to conclu-
sions about the common or consensus structure of the pro-
tein(s) to which most individuals seem to respond immu-
nologically. This structure may lead to the generation of an-
tibodies that seem to be directly involved in the production
of severe dengue pathogenesis.19–21 Also, the definition of
DHF-associated sites that do not code for proteins would
suggest that other viral replication regulators might be in-
volved in the pathogenesis of this disease. However, the as-
sociation of virulence with specific nucleotide differences in
the dengue type 2 genome will require the accumulation of
a significant amount of indirect evidence since there are cur-
rently no in vitro or in vivo models of DHF.
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FIGURE 1. Phylogenetic tree generated by phylogenetic analysis using parsimony of nucleotide sequences from the envelope/nonstructural
protein 1 junction of 77 dengue type 2 viruses and representatives of types 1, 3, and 4. Viruses are listed by strain number followed by
abbreviation for country and year (see Table 1). Branch lengths (proportional to the bar, which equals 10) represent the number of nucleotide
substitutions between viruses over the 240-nucleotide-long sequence used for comparisons. Bootstrap values are shown above the branches
that connect the genotypic groups of dengue type 2. Black squares denote samples obtained from dengue hemorrhagic fever patients.
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